Carcinogenesis Advance Access published online on April 16, 2004
Carcinogenesis, doi:10.1093/carcin/bgh167
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
* To whom correspondence should be addressed. E-mail: qwei{at}mdanderson.org.
Environmental chemicals are thought to play a role in the etiology of breast cancer, because polycyclic acromatic hydrocarbon (PAH)-DNA adducts are detectable in normal and malignant breast tissues. Peripheral blood lymphocytes (PBLs) from female breast cancer patients were more sensitive to in vitro exposure to benzo(a) pyrene diol epoxide (BPDE) than those from healthy controls. Therefore, we hypothesized that reduced DNA repair is associated with risk of breast cancer in women and the risk may be modulated by polymorphisms of DNA repair genes. In a case-control pilot study, we included 69 previously untreated female breast cancer patients and 79 controls frequency matched to the cases on age and ethnicity. The PBLs were used to measure DNA repair capacity (DRC) by using the host-cell reactivation (HCR) assay with a reporter gene damaged by exposure to 60 µM BPDE prior to transfection. We also genotyped for two common XPD polymorphisms Lys751Gln and Asp312Asn. We found that the mean DRC level was significantly lower in breast cancer patients (10.1%) than in controls (11.1%) (P = 0.008). Subjects with DRC lower than the median level of controls (11.0%) had more than 3-fold increased risk (OR = 3.36, 95% CI = 1.15-9.80) for breast cancer than did those with higher DRC after adjustment for age, smoking status and assay-related variables. None of the genotypes was statistically significantly associated with an increased risk of breast cancer, which may be due to the small number of observations in each subgroup. The XPD variant genotypes in general predicted the DRC better in the controls than in the cases, suggesting genetic variants of other DNA repair genes may be involved in these breast cancer patients. These findings suggest that women with reduced DRC may be at an increased risk of developing breast cancer. Large studies are warranted to confirm these preliminary findings. Key Words:
Host-cell reactivation, biomarkers, genetic susceptibility, molecular epidemiology, DNA repair phenotype, XPD gene polymorphism
Revised April 2, 2004
Accepted April 6, 2004
MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION
Reduced DNA repair of benzo(a)pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients
2 Department of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
3 Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. Zhao, L.-E Wang, D. Li, R. M. Chamberlain, E. M. Sturgis, and Q. Wei Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis Carcinogenesis, August 1, 2008; 29(8): 1560 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hopkins, D. W. Cescon, D. Tse, P. Bradbury, W. Xu, C. Ma, P. Wheatley-Price, J. Waldron, D. Goldstein, F. Meyer, et al. Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 490 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wang, D. Chang, F.-l. Hu, H. Sui, B. Han, D.-d. li, and Y.-s. Zhao DNA Repair Gene XPD Polymorphisms and Cancer Risk: A Meta-analysis Based on 56 Case-Control Studies Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 507 - 517. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wang, Q. Wei, Q. Shi, Z. Guo, Y. Qiao, and M. R. Spitz A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma Carcinogenesis, July 1, 2007; 28(7): 1430 - 1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Breast Cancer Association Consortium Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst, October 4, 2006; 98(19): 1382 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shen, M. Desai, M. Agrawal, D. O. Kennedy, R. T. Senie, R. M. Santella, and M. B. Terry Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1614 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Mechanic, R. C. Millikan, J. Player, A. R. de Cotret, S. Winkel, K. Worley, K. Heard, K. Heard, C.-K. Tse, and T. Keku Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study Carcinogenesis, July 1, 2006; 27(7): 1377 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Pachkowski, S. Winkel, Y. Kubota, J. A. Swenberg, R. C. Millikan, and J. Nakamura XRCC1 Genotype and Breast Cancer: Functional Studies and Epidemiologic Data Show Interactions between XRCC1 Codon 280 His and Smoking. Cancer Res., March 1, 2006; 66(5): 2860 - 2868. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bigler, C. M. Ulrich, T. Kawashima, J. Whitton, and J. D. Potter DNA Repair Polymorphisms and Risk of Colorectal Adenomatous or Hyperplastic Polyps Cancer Epidemiol. Biomarkers Prev., November 1, 2005; 14(11): 2501 - 2508. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Collini, M. Caccia, G. Chirico, F. Barone, E. Dogliotti, and F. Mazzei Two-photon fluorescence cross-correlation spectroscopy as a potential tool for high-throughput screening of DNA repair activity Nucleic Acids Res., October 21, 2005; 33(19): e165 - e165. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-M. Lee, J.-Y. Choi, C. Kang, C. P. Kang, S. K. Park, H. Cho, D.-Y. Cho, K.-Y. Yoo, D.-Y. Noh, S.-H. Ahn, et al. Genetic Polymorphisms of Selected DNA Repair Genes, Estrogen and Progesterone Receptor Status, and Breast Cancer Risk Clin. Cancer Res., June 15, 2005; 11(12): 4620 - 4626. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. Kennedy, M. Agrawal, J. Shen, M. B. Terry, F. F. Zhang, R. T. Senie, G. Motykiewicz, and R. M. Santella DNA Repair Capacity of Lymphoblastoid Cell Lines From Sisters Discordant for Breast Cancer J Natl Cancer Inst, January 19, 2005; 97(2): 127 - 132. [Abstract] [Full Text] [PDF] |
||||





